Comparison of intra articular autologous platelet-rich plasma with steroids in osteoarthritis knee: Experience from a North Indian tertiary care center

Background: Intra-articular (IA) platelet-rich plasma (PRP) is a promising treatment option for knee osteoarthritis (OA). It accelerates the process of healing, ligament repair, cartilage regeneration, and bone formation when given in supraphysiological doses. The aim of this study was to compare th...

Full description

Saved in:
Bibliographic Details
Main Authors: M N Arjun, Vivek Vasdev, Kunal Kishore, Arun Hegde, Krishnan Shanmuganandan, Abhishek Kumar, Uday Bhanu Kovilapu, Roopa Shivashankar
Format: Article
Language:English
Published: SAGE Publishing 2020-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=3;spage=165;epage=170;aulast=Arjun
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542969059606528
author M N Arjun
Vivek Vasdev
Kunal Kishore
Arun Hegde
Krishnan Shanmuganandan
Abhishek Kumar
Uday Bhanu Kovilapu
Roopa Shivashankar
author_facet M N Arjun
Vivek Vasdev
Kunal Kishore
Arun Hegde
Krishnan Shanmuganandan
Abhishek Kumar
Uday Bhanu Kovilapu
Roopa Shivashankar
author_sort M N Arjun
collection DOAJ
description Background: Intra-articular (IA) platelet-rich plasma (PRP) is a promising treatment option for knee osteoarthritis (OA). It accelerates the process of healing, ligament repair, cartilage regeneration, and bone formation when given in supraphysiological doses. The aim of this study was to compare the efficacy of IA PRP versus IA methylprednisolone acetate (MPA) in patients with knee OA. Methods: Open labeled prospective observational study was conducted on 60 patients with Kellgren-Lawrence Grade 2 and 3 OA knee, who fulfilled the ACR classification criteria for knee OA. Thirty patients were given IA PRP (6 ml) and 30 received IA methyl prednisolone (80 mg) at baseline line, which was repeated at 12 weeks. The primary endpoint was an improvement in Western Ontario and McMaster Universities Index (WOMAC) and 100 mm Visual Analog Scale (VAS) pain at 24 weeks postinjections. Results: The mean change in VAS pain and total WOMAC score from baseline to 24 weeks was 32.9 ± 12.1, 31.8 ± 14.7 for PRP group, and 12.9 ± 5.9, 7.5 ± 5.5 for MPA group, which was statistically significant (P < 0.0001). Conclusions: Treatment with IA PRP showed sustained improvements in WOMAC and VAS scores compared to IA steroids. PRP is an effective treatment for functional status and pain in moderate knee osteoarthritis.
format Article
id doaj-art-91b6e0cc55714fe88a7e6d50f3e9e494
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2020-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-91b6e0cc55714fe88a7e6d50f3e9e4942025-02-03T12:03:23ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012020-01-0115316517010.4103/injr.injr_159_19Comparison of intra articular autologous platelet-rich plasma with steroids in osteoarthritis knee: Experience from a North Indian tertiary care centerM N ArjunVivek VasdevKunal KishoreArun HegdeKrishnan ShanmuganandanAbhishek KumarUday Bhanu KovilapuRoopa ShivashankarBackground: Intra-articular (IA) platelet-rich plasma (PRP) is a promising treatment option for knee osteoarthritis (OA). It accelerates the process of healing, ligament repair, cartilage regeneration, and bone formation when given in supraphysiological doses. The aim of this study was to compare the efficacy of IA PRP versus IA methylprednisolone acetate (MPA) in patients with knee OA. Methods: Open labeled prospective observational study was conducted on 60 patients with Kellgren-Lawrence Grade 2 and 3 OA knee, who fulfilled the ACR classification criteria for knee OA. Thirty patients were given IA PRP (6 ml) and 30 received IA methyl prednisolone (80 mg) at baseline line, which was repeated at 12 weeks. The primary endpoint was an improvement in Western Ontario and McMaster Universities Index (WOMAC) and 100 mm Visual Analog Scale (VAS) pain at 24 weeks postinjections. Results: The mean change in VAS pain and total WOMAC score from baseline to 24 weeks was 32.9 ± 12.1, 31.8 ± 14.7 for PRP group, and 12.9 ± 5.9, 7.5 ± 5.5 for MPA group, which was statistically significant (P < 0.0001). Conclusions: Treatment with IA PRP showed sustained improvements in WOMAC and VAS scores compared to IA steroids. PRP is an effective treatment for functional status and pain in moderate knee osteoarthritis.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=3;spage=165;epage=170;aulast=Arjunintra-articularkneeosteoarthritisplatelet-rich plasmasteroid
spellingShingle M N Arjun
Vivek Vasdev
Kunal Kishore
Arun Hegde
Krishnan Shanmuganandan
Abhishek Kumar
Uday Bhanu Kovilapu
Roopa Shivashankar
Comparison of intra articular autologous platelet-rich plasma with steroids in osteoarthritis knee: Experience from a North Indian tertiary care center
Indian Journal of Rheumatology
intra-articular
knee
osteoarthritis
platelet-rich plasma
steroid
title Comparison of intra articular autologous platelet-rich plasma with steroids in osteoarthritis knee: Experience from a North Indian tertiary care center
title_full Comparison of intra articular autologous platelet-rich plasma with steroids in osteoarthritis knee: Experience from a North Indian tertiary care center
title_fullStr Comparison of intra articular autologous platelet-rich plasma with steroids in osteoarthritis knee: Experience from a North Indian tertiary care center
title_full_unstemmed Comparison of intra articular autologous platelet-rich plasma with steroids in osteoarthritis knee: Experience from a North Indian tertiary care center
title_short Comparison of intra articular autologous platelet-rich plasma with steroids in osteoarthritis knee: Experience from a North Indian tertiary care center
title_sort comparison of intra articular autologous platelet rich plasma with steroids in osteoarthritis knee experience from a north indian tertiary care center
topic intra-articular
knee
osteoarthritis
platelet-rich plasma
steroid
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=3;spage=165;epage=170;aulast=Arjun
work_keys_str_mv AT mnarjun comparisonofintraarticularautologousplateletrichplasmawithsteroidsinosteoarthritiskneeexperiencefromanorthindiantertiarycarecenter
AT vivekvasdev comparisonofintraarticularautologousplateletrichplasmawithsteroidsinosteoarthritiskneeexperiencefromanorthindiantertiarycarecenter
AT kunalkishore comparisonofintraarticularautologousplateletrichplasmawithsteroidsinosteoarthritiskneeexperiencefromanorthindiantertiarycarecenter
AT arunhegde comparisonofintraarticularautologousplateletrichplasmawithsteroidsinosteoarthritiskneeexperiencefromanorthindiantertiarycarecenter
AT krishnanshanmuganandan comparisonofintraarticularautologousplateletrichplasmawithsteroidsinosteoarthritiskneeexperiencefromanorthindiantertiarycarecenter
AT abhishekkumar comparisonofintraarticularautologousplateletrichplasmawithsteroidsinosteoarthritiskneeexperiencefromanorthindiantertiarycarecenter
AT udaybhanukovilapu comparisonofintraarticularautologousplateletrichplasmawithsteroidsinosteoarthritiskneeexperiencefromanorthindiantertiarycarecenter
AT roopashivashankar comparisonofintraarticularautologousplateletrichplasmawithsteroidsinosteoarthritiskneeexperiencefromanorthindiantertiarycarecenter